Mark Neumann insider trades

Open-market stock purchases and sales by Mark Neumann, Chief Commercial Officer at Veradermics, Inc, from SEC Form 4 filings since Oct 15, 2018.

Recent trades

DateStockTradeValue
Feb 3, 2026MANE Veradermics, IncBought (not open market)—

Companies traded

  • MANE Veradermics, Inc: other filings, last Feb 3, 2026
  • ITCI Intra-Cellular Therapies, Inc: 46 sales, last Apr 2, 2025

Get free alerts when Mark Neumann files a new trade →